Dr. Anita Grover
Annexon, Inc, Clinical Pharmacology
Dr. Grover is an experienced drug developer with a focus on optimizing dosing regimens for special patient populations, leveraging her clinical pharmacology expertise. Her career has spanned positions of increasing responsibility at Amgen, BioMarin Pharmaceutical, and Denali Therapeutics, and she is currently a Director at Annexon Biosciences. She completed her PhD in Pharmaceutical Sciences & Pharmacogenomics at University of California, San Francisco and her BS in Computational & Systems Biology at University of California, Los Angeles.
CRS Award Winners